美国老年成人听力损失患病率:HRS 2016至2018听力筛查数据
本研究基于HRS 2016-2018中完成HearCheck听力筛查的≥55岁参与者(n=12,756),以较好耳设备评分<6定义听力损失,并与NHANES 2015-2020纯音测听数据(n=2552)比较。
要点
- HRS筛查设备估计的听力损失患病率与NHANES测听结果高度匹配。
- HearCheck评分<6与PTA≥20dBHL定义的听力损失患病率无显著差异。
- 听力筛查工具可作为大规模人群研究中客观评估听力的替代方法。
核心结论
- HRS中基于听力筛查设备估计的听力损失患病率与NHANES基于纯音测听的估计值高度一致。
研究设计与样本
- 横断面研究,纳入HRS 2016-2018中≥55岁完成HearCheck听力筛查的参与者n=12,756,以及NHANES 2015-2020纯音测听数据n=2552。
关键数值与推荐
- HRS中听力损失定义为较好耳HearCheck设备评分<6。
- NHANES中听力损失定义为言语频率纯音平均听阈(PTA)达到预设切点,主要比较切点为PTA≥20dBHL。
临床怎么用
- 在无法进行标准化测听的大规模人群研究中,可考虑使用听力筛查工具客观评估听力损失患病率。
- 筛查工具获得的患病率估计与测听结果具有可比性,但标准化测听仍是首选。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To estimate the prevalence of hearing loss among US adults based on a hearing screening device (HearCheck) in the Health and Retirement Study (HRS), and to compare these estimates with prevalence from the National Health and Nutrition Examination Survey (NHANES) based on pure-tone audiometry. STUDY DESIGN: Cross-sectional. SETTING: HRS 2016 to 2018 and NHANES 2015 to 2020. METHODS: Study cohort included HRS participants aged ≥55 years who completed HearCheck hearing screening (n = 12,756). Hearing loss was defined using a device score<6 in the better hearing ear. For NHANES audiometry data (n = 2552), hearing loss was defined using pre-defined cut-offs of the speech-frequency pure-tone average (PTA). Prevalence was estimated using survey weights, and the estimates were compared based on two-proportion z-tests. RESULTS: Among adults aged ≥55 years, the prevalence of hearing loss in HRS was 54.8% (95% CI, 53.7%-56.0%), which closely matched the estimated prevalence in NHANES at 54.5% (51.1%-57.8%) when hearing loss was defined as PTA ≥ 20dBHL (P = .82). Further comparing the estimates, the prevalence of mild hearing difficulties (HearCheck score 3-5) in HRS at 48.8% (47.6%-49.9%) matched with the prevalence of mild to moderate hearing loss (20-49dBHL) at 48.2% (45.4%-51.1%) in NHANES (P = .70). The prevalence of moderate to severe difficulties (HearCheck score 0-2) at 6.1% (5.6%-6.5%) in HRS matched with the prevalence of moderately severe or worse hearing loss (≥50dBHL) in NHANES at 6.2% (4.8%-8.0%) (P = .82). CONCLUSION: Hearing loss prevalence estimates derived from a hearing screening device in HRS closely matched those obtained from audiometry in NHANES. While standardized audiometry is preferred, hearing screening tools offer a useful alternative for objectively assessing hearing in large-scale population studies.
引用
- Choi JS, Bokhari R, Thompson Z, et al. Hearing Loss Prevalence Among Older US Adults: HRS 2016 to 2018 Hearing Screener Data. Otolaryngol Head Neck Surg. 2026. PMID: 42808745. doi:10.1002/ohn.70451
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。